Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Nextremity Solutions, Inc. Announces Success of Initial Cases Using the InCore® TMT System


Nextremity Solutions, Inc., a strategic commercialization organization with a focus on the musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., recently completed the first several cases using its InCore TMT (Tarsometatarsal) System.

Building on the success of the proven design of the InCore Lapidus System, the InCore TMT System is a three-part construct intended for internal fixation in Lesser Tarsometatarsal Joint Arthrodesis (also known as Lisfranc Joint Fusion or 2nd/3rd Tarsometatarsal Fusion).

John G. Anderson, MD of Grand Rapids, Michigan stated, “InCore TMT is an innovative intramedullary bone fixation system for the midfoot that is easy to use, facilitates reduction of deformities. From my experience, these factors allow for early rehabilitation. The intramedullary aspect reduces the likelihood of prominent hardware that could necessitate further surgery in the form of hardware removal and is biomechanically ideal to withstand the stresses across the mid foot.”

The InCore TMT System allows for correction through the use of a Targeting Guide that provides distraction of the joint for visualization and joint preparation prior to fixation. The design of the Targeting Guide includes a built-in Compression-Distraction Fixture that provides compression parallel to the long axis of the first metatarsal.

“The unique design and intramedullary instrumentation allow for greater compression and tackles my concerns for early weight bearing after TMT joint fusion. In my opinion, early weight bearing and a high union rate leads to increased patient satisfaction,” added Donald R. Bohay, MD of Grand Rapids, Michigan.

Similar to the InCore Lapidus System, the InCore TMT System offers surgeons an intraosseous fixation option; an alternative to plating for this type of procedure. An intraosseous approach eliminates soft tissue contact which can lead to irritation in some patients since the implant is placed within bone and not on bone.

Nicholas Dodson, DPM of Valdosta, Georgia said, “The InCore TMT arthrodesis system utilizes an intraosseous fixation construct which completely eliminates the common postoperative complaint of painful hardware. The soft tissues overlying the TMT joint are very thin and not very accommodating to plates and screws in that area. By appropriately using the intraosseous fixation with InCore TMT arthrodesis, the surgeon is able to precisely place both compression screws and the titanium post with no fear of painful hardware or soft tissue irritation in the future. This is a game changer!”

Nextremity Solutions developed this technology with a team of surgeons that provide expertise in foot and ankle surgery. As part of its i3® Strategic Solutions process, this surgeon-driven approach ensures that input is received from surgeons in every stage of product development. This results in development of products that solve unmet surgeon and patient needs through technological advances not currently offered in the foot and ankle musculoskeletal space.

Michael S. Lee, DPM of Clive, Iowa concluded, “As one of the developing surgeons of the InCore TMT System, I truly believe that Nextremity Solutions has done an incredible job at listening to the needs of surgeons when it came to this system’s design and functionality. By taking what we’ve learned from the design and extensive use of the InCore Lapidus System implant and instrumentation, we were able to apply the same principles to tarsometatarsal fusion and provide an alternative to plating through an intraosseous approach. The amount of compression I am able to achieve provides the bone-to-bone apposition needed to promote healing and earlier weight bearing for my patients.”

The InCore TMT System is currently in a limited commercial launch.

To learn more about this and other products developed by Nextremity Solutions, visit http://www.nextremity.com.

About Nextremity Solutions, Inc.

Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the musculoskeletal space, offering innovative solutions and Revenue Ready® products for various extremity musculoskeletal applications and for the benefit of our industry partners. The Company’s procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

Share article on social media or email:

Lack of sleep leads to, exacerbates racial and income inequality, report says


Lack of sleep can fuel other social inequality and is particularly evident in black communities.

Tuck.com, a robust online resource dedicated to all things sleep, published a literature review showing how sleep is a mechanism connecting social inequalities to larger health effects, which cyclically stems further inequality.

The report looked at the CDC’s survey of close to 444,000 Americans that draws direct relationships between ethnicity and short sleeping (sleeping less than 7 hours). A similar connection was found between income and sleep duration, whereby those nearer to or below the poverty threshold sleep less. See the full report here: https://www.tuck.com/the-inequality-of-sleep/

The main takeaways:

  • Wealthy, white Americans get the most sleep, while people of color and low income are systematically sleeping less.
  • Nearly 46% of Black adults in the US are under-sleeping.
  • 33% of adults whose income is below the federal poverty threshold sleep less than 7 hours.
  • Short sleep contributes to a host of health issues (diminished cognitive functioning, mental health impairment, weight gain, and a 30% greater risk of mortality) and social issues (parenting, school performance, work performance, etc.), which can create multi-generational cycles of inequality.


Unequal sleep is an under-considered driver of systemic inequalities, particularly regarding ethnicity and socioeconomic status. It is a key factor in a continuous succession of worse health outcomes, and social, and economic separation.

Tuck.com is a publication dedicated to testing and evaluating sleep products, providing its readers access to comprehensive, unbiased reviews and sleep information.Tuck has been featured in outlets including NBC News, Well+Good, Shape, & Huffington Post. Visit the Tuck website, as well on social at Facebook and Twitter.

Share article on social media or email:



NeoTract Designates Dr. Mark Greenberger as UroLift® Center of Excellence


News Image

“Dr. Mark Greenberger has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Mark Greenberger, M.D., The Urology Group in Memphis, TN, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Greenberger has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Mark Greenberger has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

MRI-Linac Consortium to Use RSSearch Patient Registry to Collect and Track MRI-Guided Radiotherapy Treatment Delivery and Outcomes


News Image

The RSSearch Registry continues to grow and is a valuable resource for multi-institutional observational studies and prospective clinical trials investigating stereotactic radiotherapy and advancing therapies.

The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, today announced that the MRI-Linac Consortium will use the Radiosurgery Society’s RSSearch Patient Registry as a centralized database to collect and track treatment delivery and outcomes of patients treated with the MRI-guided radiotherapy.

The MRI-Linac Consortium will be entering prospective and retrospective data on subjects treated with MRI-guided radiotherapy across multiple tumor sites. Combining data from multiple centers will allow the consortium members to analyze the collective data and publish their findings, which will include many of the first patients treated using this MRI-guided radiotherapy. The Consortium’s initial project will focus on gastrointestinal tumors, specifically pancreas and oligometastatic disease, to explore the clinical utility of MRI-guided radiotherapy on these traditionally difficult to treat indications.

“We are embarking on a unique collaboration with the Radiosurgery Society and ViewRay to advance the science and clinical practice of MRI-guided radiotherapy,” said Michael Chuong, M.D., Director of the MRI-Guided Radiation Therapy Program at Miami Cancer Institute and member of the ViewRay Gastrointestinal Cancer Consortium. “The RSSearch Registry provides a comprehensive and flexible system where we can use existing data fields and also customize new ones specific to our study, which will facilitate the analysis of patients treated on MRIdian at various institutions across the globe. Through our contributions to the RSSearch Registry, we hope to demonstrate how MRIdian can achieve substantial clinical benefit for cancer patients.”

The RSSearch Patient Registry is an observational multi-institutional registry established to standardize data collection from patients treated with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). With data from more than 25,000 patient cases treated with SRS/SBRT, the RSSearch Patient Registry is the largest and most robust live database of its kind in the field of SRS/SBRT managed by a professional medical society.

“We are excited to support the research efforts of the Consortium to advance the field of MRI- guided radiotherapy as a new technology for cancer treatments and patient care. The RSSearch Registry continues to grow and is a valuable resource for multi-institutional observational studies and prospective clinical trials investigating stereotactic radiotherapy and advancing therapies,“ said Iris Gibbs, M.D., President of the RSS Board of Directors.

The RSSearch Patient Registry collects information including patient demographics, lesion characteristics, treatment practices and outcome information including local control, disease progression, survival, toxicity and patient-reported quality of life information. Aggregate data analysis has resulted in several publications on clinical outcomes for radiosurgery treatment of lung tumors, liver metastases, metastatic brain tumors, recurrent head and neck cancer and prostate cancer.

Initially conceptualized and designed in 2005 by a Clinical Advisory Board comprised of radiation oncologists, neurosurgeons, medical oncologists and medical physicists, the RSSearch Patient Registry provides a method to collect standardized data on the use of SRS/SBRT treatment practices and outcomes to help determine its most effective clinical use.

The RSSearch Patient Registry is managed by the RSS and the RSSearch Clinical Advisory Committee, made up of professionals involved in the management and care of patients treated with SRS/SBRT. The registry currently has 26 active sites and more than 80 trained users. Participation in the registry is voluntary and all centers treating patients with SRS/SBRT clinically are encouraged to participate. The RSSearch Patient Registry is listed on ClinicalTrials.gov (Identifier (NCT number): NCT01885299).

Interested centers should contact Jan Jenkins, RN, Clinical Program Manager at the Radiosurgery Society at jjenkins@therss.org.

About The Radiosurgery Society®

The Radiosurgery Society (RSS) – a non-profit, independent, multi-disciplinary organization of surgeons, radiation oncologists, physicists, and allied professionals, who are dedicated to advancing the science and clinical practice of radiosurgery. Originally formed in 2002 and becoming (501c6) in 2008, the Radiosurgery Society today (http://www.therss.org) represents approximately 600 members who perform stereotactic body radiotherapy and radiosurgery in hospitals and freestanding centers throughout the world.

Share article on social media or email:

RadSite Announces Complimentary Webinar Highlighting the Need for Uniform Physics Testing Protocols for Cone Beam CT Imaging


Dr. Siegel notes, “This webinar will feature thought-leaders who are working on developing uniform physics testing protocols, and it will highlight how RadSite plans to incorporate a universal methodology in its new Cone Beam CT accreditation program, scheduled to be launched this fall.”

RadSite™, a leading accreditation organization promoting quality-based imaging practices announced today that its next webinar will take place on Wednesday August 12 at 2 p.m. ET. The webinar is “Moving to a Uniform Physics Testing Protocol for Cone Beam CT Imaging”.

This webinar will describe ongoing activities to establish national standards for Cone Beam CT imaging, with a focus on physics testing. Several thought leaders will discuss recent efforts to develop a uniform phantom that will help standardize physics testing for different Cone Beam CT imaging systems. The presenters will provide a detailed overview on how Cone Beam CT imaging systems operate and how to optimize clinical and quality outputs through standardized measurement protocols.

The webinar will be moderated by Eliot Siegel, MD, RadSite’s Standards Committee Chair, and will feature the following speakers:


  • Jeff Siewerdsen, PhD, Professor, Dept of Biomedical Engineering, Johns Hopkins University
  • John M. Boone, PhD, Professor of Radiology and Chief of Medical Physics, Professor of Biomedical Engineering, University of California Davis Medical Center
  • Joshua Levy, President, The Phantom Lab

Click here to learn more about this webinar and to register.

“For the past two years, RadSite has been developing national accreditation standards for Cone Beam CT imaging,” notes Dr. Siegel. “One of the challenges for promoting quality-based and consistent Cone Beam CT imaging is the need to develop uniform physics standards, rather than the current situation in which CBCT manufacturers set their own requirements for image quality.” He adds: “This webinar will feature thought-leaders who are working on developing uniform physics testing protocols, and it will highlight how RadSite plans to incorporate a universal methodology in its new Cone Beam CT accreditation program, scheduled to be launched this fall.”

Check out RadSite’s website to learn more about future webinars or to listen to past webinars. Several of these complimentary learing opportunities provide additional background on industry and accreditation trends related to advanced diagnostic imaging (ADI), including Cone Beam CT.

RadSite offers comprehensive, affordable, quality-based accreditation programs that evaluate imaging providers on established industry standards, regulatory requirements, and best practices. Working with health plans and their participating providers also helps raise imaging standards through meaningful imaging quality and patient safety protocols. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services and more than 350 payers and radiology benefit managers.

To learn more about RadSite, visit http://www.radsitequality.com.

About RadSite™ (http://www.RadSiteQuality.com)

Founded in 2005, RadSite’s mission is to promote quality-based practices for imaging systems across the U.S. and its territories. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) as an official accreditation organization under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. RadSite’s programs help assess, track, and report imaging trends in an effort to enhance imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of patient safety issues and to promote best practices. The organization is governed by an independent board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more about RadSite, please contact us at (443) 440-6007 or info@radsitequality.com.

Share article on social media or email:

Uniform Advantage, Medical Apparel Brand Demonstrates Support of Educators Amidst COVID-19 Pandemic


Jack & Jill Teachers

Jack & Jill Teachers

Our teachers need to be able to keep themselves and their families at home safe by being able to easy wash and sanitize their clothes, and scrubs are the best option for this because they are easiest to clean and disinfect.

Uniform Advantage (UA), a multi-channel retailer of medical uniforms for medical and hospitality industries, donated $10,000 in gift cards to help support the Jack & Jill early education and elementary teachers and launched a scrub campaign for educators as schools reopen in the Fall of 2020.

The Jack & Jill Children’s Center was founded in 1942 by the Junior League of Greater Fort Lauderdale. The center began as a day-care for women whose husbands had joined the war effort and now needed to enter the workforce. It is now the Junior League’s oldest and longest running Legacy Project and has evolved into an accredited early education center for working families. Jack & Jill offers family strengthening programs to help fight the cycle of poverty in South Florida.

“We are incredibly grateful to Uniform Advantage for their generous donation of $10,000 to purchase scrubs for our teachers. The health and safety of our teachers, children, and families are at our utmost concern at this time,” said Heather Siskind Chief Executive Officer of Jack & Jill’s Children Center, “Our teachers need to be able to keep themselves and their families at home safe by being able to easy wash and sanitize their clothes, and scrubs are the best option for this because they are easiest to clean and disinfect. The scrubs allow us to have staff wearing a different color everyday thus reassuring our families that they have clean scrubs on.”

As part of their commitment to support those who support others, Uniform Advantage has launched a campaign to support educators and schools to adapt scrubs as part of their dress code. Educators will continue to play a vital role during the reopening of schools, now with a stronger demand on frequent cleaning and sanitation in the classroom. Comfortable, adaptable, durable and professional, Uniform Advantage offers scrubs for teachers that are flattering to upkeep a professional appearance with a variety of fabrics for maximum comfort, making them a considerable wardrobe option for educators.

For more information on Uniform Advantage and their contributions and partnerships visit give.uniformadvantage.com, or to shop online, please visit https://www.uniformadvantage.com/.

About Uniform Advantage                                     

Uniform Advantage has represented style, quality and, above all, customer satisfaction for more than 30 years. As the first division of UA Brands, the chain was launched with a single South Florida store in 1985. Today, the company operates 29 retail locations in key markets across the U.S.; e-commerce and print catalog divisions; plus, designs and manufactures its own proprietary healthcare apparel lines. The company’s corporate office is based in Fort Lauderdale, Florida with a distribution center near Atlanta, Georgia. Learn more at http://www.UniformAdvantage.com or by calling 800-283-8708.

Share article on social media or email:

Bad Dreams of Tooth Loss Highlight Effectiveness of Good Dental Habits and Care, says Santa Clarita Valley Dental Care


The dental group serves the entire Santa Clarita Valley area.

While a dentist cannot do much to prevent dreams of teeth loss from occurring, a good dentist can help patients maintain their oral health to ensure that these bad dreams never come true.

A July 13 article on MSN Lifestyle reports on the oddly common phenomenon of teeth falling out as the subject of vivid dreams. The article notes that almost 40 percent of the population has had a dream about their teeth “breaking, rotting or even falling out.” While science and common sense seem to suggest that stress is the most likely factor at play, the article also offers more spiritual or abstract explanations. Los Angeles county-based dental center Santa Clarita Valley Dental Care says that, while a dentist cannot do much to prevent dreams of teeth loss from occurring, a good dentist can help patients maintain their oral health to ensure that these bad dreams never come true.

Santa Clarita Valley Dental Care says that, to start, strong oral health is a result of effective routine dental hygiene practices. This means brushing teeth after each meal for about two minutes – ideally roughly thirty minutes after a meal. The dental center says that these timeframes are important for two reasons. Firstly, brushing for two minutes ensures that each surface is properly scrubbed and secondly, it ensures that enough time has passed to allow tooth enamel to re-harden before being subjected to relatively harsh brushing action. The center also notes that flossing and perhaps using mouth wash will further allow individuals to access hard-to-reach-spots in between their teeth. Additionally, by regularly taking care of one’s teeth, the center continues, people limit the chances of developing a harmful condition and thus minimize the chances of having one or more teeth fall out.

That said, Santa Clarita Valley Dental Care says that if a tooth does happen to fall out due to oral issues or trauma, it’s not the end of the world. Dental implants are made specifically for this purpose and can be a great way to restore both the function and appearance of one’s missing tooth. The dental center adds that implants are also permanent, unlike dentures, and are not at all likely to slip or fall out as they are directly secured to the patient’s jaw. Moreover, dental implants also seal open pockets in the patient’s mouth where their original teeth were set, keeping dangerous bacteria from festering in areas that are often hard or painful to touch. The center notes that dental implants also prevent, or at least significantly limit bone loss which, in extreme cases, can cause the jaw to shrink. This is because dental implants mimic the same stimulation that natural teeth place on the underlying bone structure to produce a healthy amount of bone tissue.

Readers can learn more about Santa Clarita Valley Dental Care by visiting their website at https://scvdentalcare.com/ or by calling their office at (661) 766-5566.

Share article on social media or email:

Doris Carson Williams named to Allegheny Health Network Board of Directors


“Doris is one of our region’s most respected and accomplished leaders and community advocates,” said David A. Blandino, MD, chair of the AHN board of directors.

Allegheny Health Network (AHN) announced today that Doris Carson Williams, founder and CEO of the African American Chamber of Commerce of Western Pennsylvania and president judge of the Court of Judicial Discipline, has been named to AHN’s board of directors.

Ms. Williams is also the vice-chair of the Highmark Foundation board of directors, and sits on the Highmark Inc. board. Highmark Health is AHN’s parent company.

Additionally, Ms. Williams serves on the board of directors of the Federal Reserve Bank of Cleveland. A certified member of the National Association of Chamber of Commerce Executives, she also was one of the co-chairs of the Pittsburgh G-20 Partnership, which planned for the 2009 G-20 summit.

“Doris is one of our region’s most respected and accomplished leaders and community advocates,” said David A. Blandino, MD, chair of the AHN board of directors.

“She is deeply committed to building a stronger, healthier western Pennsylvania, and to promoting equitable health care outcomes for the many communities that AHN serves. We are extremely honored and grateful that she has agreed to join the AHN board, because we know that her expertise, experience and passion will be incredibly valuable in helping us to transform health care and fulfill our charitable mission,” Dr. Blandino said.

Ms. Williams has also held leadership positions at Hartford Insurance, the Service Bureau Company (a division of Control Data Corporation), Dollar Bank, and Carnegie Museums of Pittsburgh.

About the Allegheny Health Network:

Allegheny Health Network (AHN.org), a Highmark Health company, is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 12 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, multiple employed physician organizations, home and community based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,500 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Share article on social media or email:

GMED Global Opens Second Rapid COVID-19 Testing Center In Houston


Same Day Rapid COVID-19 Test Clinics

We’re witnessing in real-time how the growing delay in accessing test results puts the health of our community at risk, so we ramped up our efforts to provide a fast, reliable solution.

As the spread of COVID-19 continues to soar in the greater Houston region, with the largest single-day spike to date and more than 110,000 positive cases, the demand for testing has surged. However, limited testing access and overwhelmed labs have throttled processing times – forcing some patients to wait as long as 14 days for results. To respond to the urgent need for effective testing to help stop the spread and support contact tracing efforts, Houston-based GMED Global, LLC, today announced the opening of its second rapid COVID-19 testing operation on Friday, August 7. GMED’s Rapid COVID Clinic will operate the newest drive-through testing facility at 3773 Southwest Freeway in Houston. COVID testing is available by appointment or for drop-ins, with results provided the same day.

This unique test, manufactured by Quidel, is one of the few rapid antigen tests in the country. It provides a pain-free nasal swab that can be self-administered – minimizing the exposure between test takers and health care providers. This highly accurate test directly detects the presence of COVID-19 and test results are returned electronically in about one hour.

“We’re witnessing in real-time how the growing delay in accessing test results puts the health of our community at risk, so we ramped up our efforts to provide a fast, reliable solution,” said Dr. Ramin Ahmadi, Co-founder and Chief Medical Officer of GMED. “By opening a second test facility, we’re giving Houstonians greater access to fast, anxiety-free, and highly efficient COVID tests. Through aggressive testing efforts, we can offer early intervention for treatment, slow the spread of the novel coronavirus in the greater Houston area, and save lives.”

In addition to confirming the virus in both symptomatic and asymptomatic individuals, negative test results can also be used to return to work and travel safely. GMED also offers on-site COVID-19 screening to area businesses, federal health clinics, and schools.

The test does not require a doctor’s referral. Individuals can schedule an online appointment or drive to the testing site. For more information about cost, testing sites, rules, procedures and hours of operation, or to schedule an appointment visit http://www.rapidcovidclinic.com.

Share article on social media or email:

Julie Halston Joins Pulmonary Fibrosis Foundation Board of Directors


Julie Halston, PFF Board of Directors

“I am deeply honored and grateful to join the Board of Directors of the PFF. I look forward to playing a larger role in the crucial work leading to improved treatments, research and care for those living with this devastating disease,” said Halston.

The Pulmonary Fibrosis Foundation (PFF), the nation’s leading pulmonary fibrosis (PF) patient education and advocacy organization, has appointed actress and comedienne, Julie Halston, to its Board of Directors. Halston has supported the PF community for 10 years as host and a founder of the annual Broadway Belts for PFF! benefit in New York City.

Pulmonary fibrosis is a progressive, debilitating lung disease with different causes that affects more than 200,000 Americans. Over 50,000 new cases are diagnosed annually. There is no known cure.

“I am deeply honored and grateful to join the Board of Directors of the PFF. I look forward to playing a larger role in the crucial work leading to improved treatments, research and care for those living with this devastating disease,” said Halston, who is best known for her Broadway roles in Tootsie, Hairspray, Gypsy and You Can’t Take It With You.

Broadway Belts for PFF! features legendary Broadway stars who sing their favorite show tunes in a gala evening benefiting the PFF. Since its inception in 2010, the event has raised more than $2 million and is now the PFF’s single-largest fundraiser.

“Julie has generously devoted herself and has inspired many Broadway celebrities to help raise awareness and funds for PF research and patient programs,” said George Eliades, Chair of the PFF Board of Directors. “She is a talented and passionate advocate for our community and we are delighted to welcome her to the PFF board.”

In 2010, Halston joined Broadway friends D. Michael Dvorchak, Sue Frost, and Ed Windels, in creating a memorial tribute to honor long-time Associated Press theater critic, Michael Kuchwara, who had succumbed to PF. Halston’s late husband, Ralph Howard, was battling PF at the time Halston came on board as emcee for the show. He received a life-extending lung transplant that year. Howard passed away from complications from the disease in 2018.

About the Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation (PFF) mobilizes people and resources to provide access to high quality care and leads research for a cure so people with pulmonary fibrosis will live longer, healthier lives. The PFF collaborates with physicians, organizations, patients, and caregivers worldwide. The PFF has a three-star rating from Charity Navigator and is a Better Business Bureau and National Health Council accredited charity. For more information, visit pulmonaryfibrosis.org or call 844.TalkPFF (844.825.5733) or 312.587.9272 from outside the U.S.

Contact: Dorothy Coyle, 773-332-6201, dorothyccoyle@gmail.com

Share article on social media or email: